We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SENATOR TELLS FDA TO USE CAUTION ON GENERIC BIOLOGICS
SENATOR TELLS FDA TO USE CAUTION ON GENERIC BIOLOGICS
April 9, 2004
A U.S. senator, alarmed by the growing momentum at the FDA toward developing an approval process for generic biologics, has urged the agency to address the legal and regulatory foundations before releasing a scientific guidance for producing the complex products.